MPO Movers

MPO’s Most-Read Stories This Week—Jan. 11

A listing of the most popular items from the past seven days.

Author Image

By: Rachel Klemovitch

Assistant Editor

M&A activity is off to a fast start in 2025, as Stryker and Boston Scientific make deals to expand their portfolios. 

Stryker’s deal to acquire Inari Medical is valued at about $4.9 billion and complements Stryker’s neurovascular business. Inari offers solutions for VTE clot removal without the use of thrombolytic drugs.

Boston Scientific has agreed to buy Bolt Medical, the developer of an intravascular lithotripsy (IVL) laser-based platform to treat coronary and peripheral artery disease. Boston Scientific is a strategic investor of Bolt, so this deal is for the 74% stake the company does not already own. 

A new AI-powered app that detects sleep apnea was launched at CES 2025. APNEAL’s app allows your smartphone to collect data points such as respiratory movements, heartbeats, and sounds of breathing that are analyzed by AI, which is then made available to healthcare professionals. 

Readers caught up on online exclusives; one on deregulation in the US and one on AI and cybersecurity. With a new presidential era on its way, Matthew Burton explained the potential outcomes for the medical devices sector under the prospective deregulatory framework. Rekha Ranganathan provided some preventive measures organizations can take to ensure the safety of their data heading into 2025.

  1. CES 2025: APNEAL Unveils the World’s First AI-Powered App to Detect Sleep Apnea
  2. Deregulation in the US: A Mixed Impact on the International Medical Device Market
  3. Leveraging AI and Cybersecurity to Improve Operational Efficiency in 2025
  4. Stryker to Acquire Inari Medical for $4.9 Billion
  5. Boston Scientific to Buy IVL Company Bolt Medical

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters